Pyruvate Kinase, Liver and RBC (PKLR) Peptid

Details zu Produkt Nr. ABIN981814, Anbieter: Anmelden zum Anzeigen
Proteinname
  • PK1
  • PKL
  • PKR
  • PKRL
  • RPK
  • Pklg
  • wu:fd15e01
  • wu:fi37e08
  • pk1
  • PKLR
  • Pk-1
  • Pk1
  • R-PK
  • pklr
  • pyruvate kinase L/R
  • pyruvate kinase, liver and RBC
  • pyruvate kinase, liver and RBC L homeolog
  • pyruvate kinase liver and red blood cell
  • pyruvate kinase PKLR-like
  • PKLR
  • Pklr
  • pklr
  • pklr.L
  • LOC100621940
Spezies
Human
3
2
2
2
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PKLR antibody (Catalog #: ARP41699_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Proteinname
Hintergrund PKLR is a pyruvate kinase that catalyzes the production of phohsphoenolpyruvate from pyruvate and ATP. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA).The protein encoded by this gene is a pyruvate kinase that catalyzes the production of phohsphoenolpyruvate from pyruvate and ATP. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Alternatively spliced transcript variants encoding distinct isoforms have been described.

Alias Symbols: PK1, PKL, RPK, PKR, PKRL

Protein Interaction Partner: MYOC,ARHGEF6,KIF23,OTUD5,PAK1,PXN,USP3,USPL1

Protein Size: 543
Molekulargewicht 58 kDa
Gen-ID 5313
NCBI Accession NM_181871, NP_870986
Applikations-hinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.